➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Express Scripts
Harvard Business School
McKesson
Baxter
Boehringer Ingelheim
Johnson and Johnson

Last Updated: August 10, 2020

DrugPatentWatch Database Preview

Acerus Company Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What is the competitive landscape for ACERUS, and when can generic versions of ACERUS drugs launch?

ACERUS has one approved drug.

There are four US patents protecting ACERUS drugs.

There are twenty-four patent family members on ACERUS drugs in twenty-one countries.

Summary for Acerus
International Patents:24
US Patents:4
Tradenames:1
Ingredients:1
NDAs:1

Drugs and US Patents for Acerus

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Acerus NATESTO testosterone GEL, METERED;NASAL 205488-001 May 28, 2014 RX No No 8,877,230   Start Trial   Start Trial
Acerus NATESTO testosterone GEL, METERED;NASAL 205488-001 May 28, 2014 RX No No 8,574,622   Start Trial Y   Start Trial
Acerus NATESTO testosterone GEL, METERED;NASAL 205488-001 May 28, 2014 RX No No 8,784,882   Start Trial Y   Start Trial
Acerus NATESTO testosterone GEL, METERED;NASAL 205488-001 May 28, 2014 RX No No 8,784,869   Start Trial Y   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Mallinckrodt
McKesson
Boehringer Ingelheim
AstraZeneca
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.